Analyze Diet

Effects of aflatoxins in young ponies.

Abstract: Sixteen clinically normal, healthy ponies were randomly assigned to 4 groups and given aflatoxin B1 in doses of 0.045, 0.030, 0.015, and 0 (control) mg/kg of body weight per day for 21 days (or total doses of 0.945, 0.630, 0.315, and 0 mg/kg). The animals were allowed to recover for 3 months and then were reassigned to 4 treatment groups such that each group during the 2nd trial included a pony from each of the groups of the 1st trial. The animals in the new groups were intubated and were given aflatoxin in doses of 0.4, 0.2, 0.1, and 0 (control) mg/kg/day for 5 days ( or total doses of 2.0, 1.0, 0.5, and 0 mg/kg). Venous blood samples were drawn every other day to monitor for toxicosis; examinations were made for RBC and WBC counts, hemoglobin concentration, PCV, serum urea nitrogen, prothrombin time, and serum concentrations of aspartate aminotransferase, iditol dehydrogenase, alkaline phosphatase, albumin, gamma-glutamyl transferase, and arginase. There were no significant differences between treatment groups and controls (given no aflatoxin) in the toxicologic values examined for during the 1st trial. During the 2nd experiment, 2 of the ponies in the large-dose treatment gorup (2.0 mg/kg) demonstrated increased serum enzyme activities. These animals had been in the large-dose (0.945 mg/kg) and median-dose (0.63 mg/kg) groups during the 1st trial. Arginase, iditol dehydrogenase, and gamma-glutamyl transpeptidase activities became increased on the 4th day of treatment and continued to increase until the 6th day of the experiment (1 day after treatment was terminated). These enzymes approached control group values at 10 days after cessation of treatment. These increases were indicative of hepatocellular toxicity. It was concluded that the possibility of equine aflatoxicosis exists although ponies given high quality rations appear to be less susceptible than some other species. Prior exposure to aflatoxins may predispose to clinical toxicity on subsequent exposure, despite lack of expression of clinical signs.
Publication Date: 1981-12-01 PubMed ID: 6122412
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigates the impact of aflatoxins on young ponies and suggests that, although instances of toxicity were relatively rare, a potential for aflatoxin poisoning in horses exists, potentially intensified by prior exposure to the toxin.

Research Method

  • Sixteen healthy ponies were split into four groups and assigned different doses of aflatoxin B1. These ranges were 0.045, 0.030, 0.015, and 0 mg/kg of body weight per day for 21 days, adding up to total doses of 0.945, 0.630, 0.315, and 0 mg/kg respectively.
  • The ponies took a break to recover for three months, after which researchers assigned them to four new treatment groups for a second trial. In this trial, each group included a pony from each group of the first trial. The doses of aflatoxin they received were of 0.4, 0.2, 0.1, and 0 mg/kg per day for five days, producing total doses of 2.0, 1.0, 0.5 and 0 mg/kg.
  • Blood samples from ponies were taken every other day to check for signs of toxicosis. The values measured included red and white blood cell counts, hemoglobin concentration, serum urea nitrogen, prothrombin time, and serum concentrations of various enzymes.

Findings

  • During the first trial, there were no significant differences found in toxicological values between the various treatment groups and the controls, who received no aflatoxin.
  • However, during the second trial, two out of the ponies that received the largest dose of 2.0 mg/kg (one from the trial group who had a high exposure of 0.945 mg/kg and one from the median exposure group of 0.63 mg/kg in the first trial) displayed raised serum enzyme activities.
  • The increased enzyme activities were indicative of hepatocellular toxicity. Notably, these abnormal values approached control group levels about ten days after the aflatoxin treatment ended.

Conclusion

  • The research concludes that equine aflatoxicosis is possible. However, ponies given high-quality food appear to be less susceptible to aflatoxin toxicity than other species.
  • Importantly, the study also infers that exposure to aflatoxins may cause an increased risk of toxicity on subsequent exposures, even if there are no apparent symptoms of toxicity during the initial exposure.

Cite This Article

APA
Aller WW, Edds GT, Asquith RL. (1981). Effects of aflatoxins in young ponies. Am J Vet Res, 42(12), 2162-2164.

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 42
Issue: 12
Pages: 2162-2164

Researcher Affiliations

Aller, W W
    Edds, G T
      Asquith, R L

        MeSH Terms

        • Aflatoxin B1
        • Aflatoxins / toxicity
        • Animals
        • Arginase / blood
        • Horse Diseases / blood
        • Horse Diseases / chemically induced
        • Horses
        • L-Iditol 2-Dehydrogenase / blood
        • gamma-Glutamyltransferase / blood

        Citations

        This article has been cited 1 times.
        1. Peden WM, Richard JL, Thurston JR, Sacks JL. Effects of pre-treatment with aflatoxin on a second aflatoxin treatment in guinea pigs.. Mycopathologia 1987 Aug;99(2):107-14.
          doi: 10.1007/BF00436914pubmed: 3116429google scholar: lookup